Absci Investor Presentation Deck
CASE STUDY: DESIGNING BETTER HER2 BINDERS
Al models expanded search
space by orders of magnitude
yo
CDR1 CDR2 CDR3
Amino acids ARNDOEG
Heavy chain detail
CDR1
CDR2
OOOOOOOOOO
OOOOOOOOOO
OOOOOOOOOO
Heavy Chain
Light Chain
ABSCI CORPORATION 2023 ALL RIGHTS RESERVED
EPSTWYV &
JI
OOO
CDR3
OOOOOO
DOOO
OOO
All possible triple mutants of
19 amino acids in 20 positions
(HCDR2 & HCDR3)
Sampled space.
(50k Variants)
Hypothetical
sequence space
7x 106
ā
ā
Bachas, S., Rakocevic, G. et al., "Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness," 2022 pre-print in bioRxiv.
Combinatorial mutagenesis of up
to 3 mutations over ten amino
acids each in HCDR2 and HCDR3
Sampled less than 1% of the
sequence space
Measured binding affinity of
nearly 50,000 sequence variants
absci. 22View entire presentation